NewAmsterdam Pharma Company N.V. (NAMS)

NAMS Revenue

NewAmsterdam Pharma Company had revenue of $19.15M in the quarter ending June 30, 2025, with 740.06% growth. This brings the company's revenue in the last twelve months to $64.01M, up 762.15% year-over-year. In the year 2024, NewAmsterdam Pharma Company had annual revenue of $45.56M with 223.37% growth.

• Revenue (ttm): $64.01M
• Revenue Growth: +762.15%
• P/S Ratio: 51.38
• Revenue / Employee: $941,265
• Employees: 68
• Market Cap: 3.45B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	45.56M	31.47M	223.37%
Dec 31, 2023	14.09M	-88.60M	-86.28%
Dec 31, 2022	102.69M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.